Andreas K Buck Selected Research

Andreas K Buck Research Topics

Disease

84	Neoplasms (Cancer) 01/2024 - 09/2003
37	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 10/2009
20	Neoplasm Metastasis (Metastasis) 02/2024 - 12/2003
17	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 09/2012
17	Multiple Myeloma 01/2023 - 10/2003
16	Lymphoma (Lymphomas) 12/2023 - 11/2006
11	Thyroid Neoplasms (Thyroid Cancer) 12/2023 - 04/2012
10	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 12/2008
8	Adrenocortical Carcinoma 02/2024 - 03/2012
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2023 - 02/2016
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 06/2007
5	Inflammation (Inflammations) 01/2022 - 09/2012
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2013
4	Meningioma (Meningiomas) 05/2020 - 06/2012
4	Glioma (Gliomas) 12/2019 - 10/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 04/2014
4	Leukemia 01/2019 - 06/2007
3	Pheochromocytoma 06/2022 - 03/2010
3	Carcinoma (Carcinomatosis) 10/2018 - 03/2003
3	Myocardial Infarction 10/2018 - 09/2015
3	Breast Neoplasms (Breast Cancer) 10/2015 - 03/2003
3	Stomach Neoplasms (Stomach Cancer) 11/2011 - 12/2007
2	Wounds and Injuries (Trauma) 11/2023 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2021
2	Hypersensitivity (Allergy) 01/2023 - 11/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 11/2007
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022 - 10/2022
2	Adrenocortical Adenoma (Disease, Conn's) 11/2022 - 01/2018
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 07/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 05/2011
2	Parkinsonian Disorders (Parkinsonism) 10/2019 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 09/2009
2	medullary Thyroid cancer 01/2019 - 04/2015
2	Sarcoidosis (Schaumann Disease) 01/2018 - 12/2016
2	Ischemic Stroke 01/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

37	Chemokine ReceptorsIBA 02/2024 - 04/2015
28	AntigensIBA 03/2024 - 06/2015
28	68Ga-pentixaforIBA 12/2023 - 12/2015
22	Radioisotopes (Radionuclides)IBA 11/2023 - 03/2012
20	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2023 - 01/2011
20	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021 - 09/2003
19	Peptide Receptors (Peptide Receptor)IBA 06/2023 - 06/2012
13	Biomarkers (Surrogate Marker)IBA 07/2023 - 09/2003
12	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 06/2004
10	ThymidineIBA 01/2014 - 06/2002
7	PSMA I&TIBA 03/2024 - 01/2022
7	Edotreotide (SMT 487)IBA 06/2022 - 01/2011
7	alovudineIBA 07/2014 - 09/2003
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
6	Amino Acids FDA Link 12/2019 - 07/2010
5	Choline (Choline Chloride)IBA 08/2019 - 10/2009
5	Methionine (L-Methionine)FDA Link 08/2019 - 09/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 06/2007
4	IodineIBA 12/2023 - 11/2011
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2023 - 01/2011
4	Rituximab (Mabthera)FDA Link 01/2023 - 06/2007
4	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 01/2013
4	LigandsIBA 10/2022 - 02/2016
4	fluorodopa F 18IBA 10/2014 - 03/2010
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 10/2022
3	RadiopharmaceuticalsIBA 12/2023 - 01/2011
3	Indicators and Reagents (Reagents)IBA 10/2022 - 12/2014
3	Dihydroxyphenylalanine (Dopa)IBA 06/2022 - 03/2010
3	iodophenyl metomidateIBA 12/2021 - 03/2012
3	gallium 68 PSMA-11IBA 01/2020 - 06/2015
3	ChemokinesIBA 10/2018 - 01/2016
3	Caspase 3 (Caspase-3)IBA 01/2014 - 11/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2011 - 06/2007
2	Peptides (Polypeptides)IBA 12/2023 - 11/2016
2	90Y-pentixatherIBA 12/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 04/2009
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2022
2	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 07/2022 - 01/2018
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 07/2008
2	Lutetium-177IBA 01/2022 - 01/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 07/2008
2	Ga(III)-DOTATOCIBA 01/2021 - 01/2011
2	CXC ChemokinesIBA 12/2020 - 01/2017
2	Gallium-68IBA 01/2020 - 01/2018
2	ioflupaneIBA 10/2019 - 01/2019
2	CXCR ReceptorsIBA 10/2019 - 01/2018
2	vandetanib (ZD6474)IBA 01/2019 - 01/2018
2	HexokinaseIBA 01/2019 - 06/2004
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2018
2	AcidsIBA 12/2018 - 09/2012
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017 - 04/2014
2	Octreotide (Sandostatin)FDA LinkGeneric 04/2014 - 06/2012
2	Sodium Fluoride (Ossin)FDA Link 04/2014 - 12/2003
2	Cytostatic AgentsIBA 01/2014 - 06/2009
2	Cytotoxins (Cytolysins)IBA 01/2013 - 11/2008

Therapy/Procedure

68	Therapeutics 03/2024 - 03/2003
18	Precision Medicine 02/2024 - 01/2017
15	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
13	Castration 03/2024 - 01/2021
9	Radiotherapy 10/2022 - 06/2007
5	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2018
4	Radioimmunotherapy 01/2023 - 11/2007
4	Stem Cell Transplantation 01/2022 - 09/2014
2	Thyroidectomy 03/2018 - 09/2009
2	Prostatectomy (Retropubic Prostatectomy) 12/2016 - 10/2009